期刊文献+

超声的BI-RADS分类对微小乳腺癌的诊断价值 被引量:6

Analysis of Diagnosis Value of Ultrasound BI-RADS for Breast Tiny Carcinoma
下载PDF
导出
摘要 目的探讨超声的美国放射学院乳腺影像报告和数据系统(breast imaging reporting and data systern,BI-RADS)分类对微小乳腺癌的诊断价值。方法回顾性分析超声的BI-RADS分类的98例微小乳腺病灶的病理结果、分级结果与超声征象。结果超声的BI-RADS分类对微小乳腺癌的阳性预测值、阴性预测值、敏感度、特异度以及准确度分别为88.46%、83.33%、65.71%、95.23%和84.69%。恶性病灶组边缘不光整、形态不规则、内部有微钙化、后方回声衰减、周围组织改变、纵横比≥1以及内部血流RI≥0.7的占比显著高于良性病灶组,差异具有统计学意义(P<0.05)。结论超声的BI-RADS分类可客观地评价微小乳腺病灶的良恶性。 Objective To discuss the ultrasound breast imaging reporting and data systern(BI-RADS)in the diagnosis of breast tiny carcinoma.Methods Retrospectively analyzed ultrasound features,BI-RADS classification and pathological results of 98 small breast lesions diagnosed to be ultrasound BI-RADS.Results The positive predictive value,negative predictive value,sitivity,specificity and accuracy of ultrasound BI-RADS classi-fication were 88.46%,83.33%,65.71%,95.23%and 84.69%,respectively.The differences in non-circumscribed margin,irregular shape,microcalcification in mass,shadowing,the changes of surrounding tissue,aspect ratio>1 and lesions internal resistance index(RI)≥0.7 between Benign lesions group and Malignant lesions group were statistically significant different(P<0.05).Conclusion BI-RADS classification of ultrasound can objectively evaluate benign and malignant breast lesions.
作者 李英 许伦 LI Ying;XU Lun(Zigong Fourth People's Hospital,Zigong,643000)
出处 《实用癌症杂志》 2019年第8期1338-1340,共3页 The Practical Journal of Cancer
基金 四川省卫生和计划生育委员会科研课题(编号:17PJ413)
关键词 微小乳腺癌 多普勒 超声检查 乳腺影像报告和数据系统 Small breast lesions Doppler Ultrasound examination Breast imaging reporting and data systern
  • 相关文献

参考文献8

二级参考文献62

  • 1朱雪萍,王雷,茅瑾瑜,章丽洁,徐君镛.超声引导下乳腺小病变的活检[J].上海医学影像,2007,16(1):45-46. 被引量:6
  • 2Abkevich V, Timms KM, Hennessy BT, et al. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithehal o,~arian cancer [ J ]. Br J Cancer, 2012, 107 ( 10 ) : 1776-1782. 被引量:1
  • 3Liedtke C, Hess KR, Karn T, et al. The prognostic impact of age in patients with triple-negative breast cancer [ J ]. Breast Cancer ResTreat, 2013, 138(2) : 591-599. 被引量:1
  • 4Medimegh I, Omrane I, Privat M, et al. MieroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interac- tion with clinical outcome[ Jl. PLoS One, 2014, 9( 11 ): e111877. 被引量:1
  • 5Lehmann BD, Bauer JA, Chen X, et al. Identification of human tri- ple-negative breast cancer subtypes and preclinieal models for selec- tion of targeted therapies[J]. J Clin Invest, 2011, 121 (7): 2750- 2767. 被引量:1
  • 6Bousquet G, Feugeas JP, Ferreira I, et al. Individual xenograft as a personalized therapeutic resort for women with metastatic triple-nega- tive breast carcinoma[ J]. Breast Cancer Res, 2014, 16 (1) : 401. 被引量:1
  • 7Narod SA, Salmena L. BRCA1 and BRCA2 mutations and breast cancer[J]. Discov Med, 2011, 12(66) : 445-453. 被引量:1
  • 8Fasano J, Muggia F. Breast cancer arising in a BRCA-mutated back- ground: therapeutic implications from an animal model and drug de- velopment[J]. Ann Oneol, 2009, 20 (4): 609-614. 被引量:1
  • 9Kojima Y, Tsunoda H, Honda S, et al. Radiographic features for tri- ple negative ductal carcinoma in situ of the breast [ J ]. Breast Cancer, 2011, 18(3):213-220. 被引量:1
  • 10Walerych D, Napoli M, Collavin L, et al, The rebel angel: mu-ant p53 as the driving oncogene in breast cancer [ J 1. Carcinogenesis, 2012, 33 ( 11 ) : 2007-2017. 被引量:1

共引文献98

同被引文献73

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部